|
PCNT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.244900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.124000E-02 |
| Normal-vs-Stage2 |
4.946400E-02 |
| Normal-vs-Stage3 |
3.839400E-04 |
| Normal-vs-Stage4 |
3.201200E-03 |
| Stage1-vs-Stage2 |
5.711800E-01 |
| Stage1-vs-Stage3 |
5.111800E-02 |
| Stage1-vs-Stage4 |
1.638560E-01 |
| Stage2-vs-Stage3 |
4.726600E-01 |
| Stage2-vs-Stage4 |
5.493000E-01 |
| Stage3-vs-Stage4 |
9.607200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.895400E-03 |
| Normal-vs-AfricanAmerican |
6.686800E-01 |
| Normal-vs-Asian |
5.315600E-02 |
| Caucasian-vs-AfricanAmerican |
1.664570E-01 |
| Caucasian-vs-Asian |
9.469000E-01 |
| AfricanAmerican-vs-Asian |
2.696600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.577600E-03 |
| Normal-vs-Female |
5.356300E-03 |
| Male-vs-Female |
3.939200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.466500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.629500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.609920E-02 |
| Normal-vs-Age(81-100Yrs) |
4.924200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.319370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.191800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.607200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.628200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.399200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.570000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.522899999997E-05 |
| Classical-VS-Follicular |
1.994040E-01 |
| Classical-VS-Other |
3.321400E-01 |
| Classical-VS-Normal |
7.093700E-02 |
| Tall-VS-Follicular |
1.660250E-02 |
| Tall-VS-Other |
3.533800E-01 |
| Tall-VS-Normal |
2.35959999994595E-06 |
| Follicular-VS-Other |
7.024800E-01 |
| Follicular-VS-Normal |
1.170160E-02 |
| Other-VS-Normal |
6.256300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.262100E-03 |
| Normal-vs-N1 |
1.321430E-03 |
| N0-vs-N1 |
2.872600E-01 |
|
|
